Our speaking faculty consist of the “Who’s Who” of pharma and biotech patent litigation to Assist You with Practical Knowledge to Advance Your Patent Strategy.
DOWNLOAD THE EVENT AGENDA
If you wish to get involved, contact [email protected] for further information
Atabak Royaee
Senior Director Assistant General CounselRegeneron PharmaceuticalsBart Newland
General CounselAtalanta TherapeuticsChris Sharp
PartnerPinsent MasonsHon. Paul R. Michel (Ret.)
Former Chief JudgeUnited States Court of Appeals for the Federal Circuit (CAFC)Dan McGrath
Managing AssociateMarks & ClerkJohn Cox
PartnerBarnes & ThornburgWith deep knowledge of issues facing the life sciences industry, John Cox counsels clients regarding their worldwide intellectual property rights and represents their patent interests when litigation arises, particularly regarding pharmaceutical, chemical, and biotechnology matters. John takes his role in protecting these important assets of life science innovators very seriously while approaching each matter with enthusiasm.
Through his ability to communicate effectively and succinctly, John advises on, develops, and carries out global IP strategies for the benefit of innovative companies, his clients, who are focused on developing core assets that save and improve the lives of patients. John enjoys leveraging his unique ability to put together targeted and enduring teams for each matter – paying close attention to each person’s strengths and skillsets and how they fit with one another, alongside his highly specialized experience and thoughtful and responsive nature.
John is intimately familiar with the pharmaceutical industry, having dealt with patent and IP subject matter ranging from brain chemistry, the gastrointestinal system, drug delivery systems and treatments of rare diseases and cancer to medical diagnostic methods, the generation of biofuel using bacteria, and processes for manufacturing chemicals and pharmaceutical products. He also has almost two decades of experience in Abbreviated New Drug Application (ANDA) cases, including pre-litigation investigations.John offers guidance from the first step of a matter through to resolution, including all aspects of litigation. He has extensive experience related to discovery and motion practice, as well as in developing offensive and defensive strategies. He is well versed in dealing with complex subject matter and technical witnesses, such as inventors and experts.
John adeptly helps clients navigate the crossroads of foreign business practices and the complexities of U.S. patent practice, having worked with foreign pharmaceutical, chemical, and biotechnology companies throughout his career.Joshua Kresh
Interim Executive Director of the Center for Intellectual Propertyx Innovation PolicyHon. Mitchell S. Goldberg
JudgeUnited States District Court, Eastern District of PaKristin Cooklin
Group Head IP CounselRecordatiDr. Leslie Fischer
Principal Patent AttorneySandozLeslie Fischer is a Principal Patent Attorney at Sandoz, who focuses on global IP strategy for biosimilars. Before joining Sandoz, Leslie was a patent attorney at Novartis Pharmaceuticals, where she worked for over a decade developing global patent portfolios for biologicals. Before joining the Novartis group, Leslie was an associate at Fitzpatrick Cella (NY) (now Venable). Leslie holds a J.D. from Rutgers University and a Ph.D. in Biochemistry from Thomas Jefferson University. Her scientific work appears in JCB, JBC, and Osteoarthritis & Cartilage. She speaks frequently at patent-related events and is an adjunct professor at Seton Hall Law School.
Marina Volin
General CounselNordic PharmaPaul Inman
PartnerGowlingWith more than 25 years' experience of litigating intellectual property (IP) disputes both within the UK and internationally, Paul Inman works with companies ranging from small start-ups to major multi-national corporations. He specialises in the life sciences sector, which includes acting on high-profile pharmaceutical patent infringement cases in the UK Patents Court.
Paul provides life science businesses with commercial advice from an international outlook. His specialist experience ideally places him to provide this expertise and client care, with the ultimate aim of delivering well-rounded advice and guidance to ensure the best possible outcome.
As well as litigating in the English courts, he has co-ordinated and advised on IP and regulatory litigation matters across the globe; from all over Europe and the US, to as far afield as Asia, South Africa, Australia and New Zealand.
Successfully guiding clients through the maze of litigation is where Paul's strength lies, having now been involved over 25 years of litigation in cases leading to more than 40 reported judgments. These range from the tribunals of the UK Patent Office up to the House of Lords, European Patent Office and European Court of Justice.
Paul also has a degree in Molecular Biology and Biochemistry and during his professional career has established an outstanding reputation in the market. He is distinguished in the 2023 edition of IAM Patent 1000: The World's Leading Patent Professionals, ranked individually for both IP law and life sciences law in the peer review publication 'Best Lawyers® in the UK' and recognised in several categories within Chambers & Partners UK 2023.
Petra Scamborova
Senior Director, Assistant General Counsel, Dispute ResolutionRegeneronPhilip Caramanica
Chief IP Counsel & Deputy General CounselAlvotechRhian Kalden
Juge Court of AppealUnified Patent CourtRobin Ellis
PartnerReddie&GroseSesha Kumar
Vice President & Head-Intellectual Property, InnovationDr. Reddy’s LaboratoriesStephanie Monaco
General Counsel and Head of Regulatory AffairsKindeva Drug DeliveryVictoria Reines
Principal CounselSanofiYu Ming Dammann
Senior Associate General Counsel, Head of Intellectual PropertyKite Pharmaceuticals IncWilliam Simmons
Senior CounselJohnson & Johnson